Search Results - "Burch, Patrick A"
-
1
EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer
Published in Gastrointestinal endoscopy (01-07-2017)“…Background and Aims Among the greatest hurdles to pancreatic cancer (PC) therapy is the limited tissue penetration of systemic chemotherapy because of tumor…”
Get full text
Journal Article -
2
Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916
Published in Journal of clinical oncology (20-05-2009)“…Prostate-specific antigen progression (PSA-P) is an indicator of progression in hormone-sensitive (HS) and castration-resistant (CR) prostate cancer (PC). We…”
Get full text
Journal Article -
3
Obesity adversely affects survival in pancreatic cancer patients
Published in Cancer (01-11-2010)“…BACKGROUND: Higher body‐mass index (BMI) has been implicated as a risk factor for developing pancreatic cancer, but its effect on survival has not been…”
Get full text
Journal Article -
4
Evaluation of Prostate-Specific Antigen Declines for Surrogacy in Patients Treated on SWOG 99-16
Published in JNCI : Journal of the National Cancer Institute (19-04-2006)“…Background: The identification of surrogate endpoints that can replace true outcome endpoints is crucial to the rapid evaluation of new cancer drugs…”
Get full text
Journal Article -
5
Immunotherapy (APC8015, Provenge®) targeting prostatic acid phosphatase can induce durable remission of metastatic androgen-independent prostate cancer: A phase 2 trial
Published in The Prostate (01-08-2004)“…BACKGROUND Prostate cancer is the most commonly diagnosed malignancy in American men, yet treatment of its metastatic androgen‐independent form remains…”
Get full text
Journal Article -
6
The Prognostic Value of Clinical and Pathologic Factors in Esophageal Adenocarcinoma: A Mayo Cohort of 796 Patients With Extended Follow-up After Surgical Resection
Published in Mayo Clinic proceedings (01-12-2010)“…OBJECTIVE To identify and describe clinicopathologic prognostic factors in patients with esophageal adenocarcinoma who underwent surgical resection with…”
Get full text
Journal Article -
7
Quality of Life and Pain in Advanced Stage Prostate Cancer: Results of a Southwest Oncology Group Randomized Trial Comparing Docetaxel and Estramustine to Mitoxantrone and Prednisone
Published in Journal of clinical oncology (20-06-2006)“…Palliation of bone pain can be achieved in men with androgen-independent prostate cancer treated with docetaxel and estramustine (DE) or mitoxantrone and…”
Get full text
Journal Article -
8
Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer
Published in Cancer (15-08-2009)“…BACKGROUND: Sipuleucel‐T is an investigational active cellular immunotherapy product designed to stimulate an immune response against prostate cancer. The…”
Get full text
Journal Article -
9
Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson
Published in Journal of clinical oncology (01-06-2016)“…The inclusion of metformin in the treatment arms of cancer clinical trials is based on improved survival that has been demonstrated in retrospective…”
Get full text
Journal Article -
10
Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer
Published in The New England journal of medicine (07-10-2004)“…This large, randomized trial compared docetaxel plus estramustine with mitoxantrone plus prednisone in men with androgen-independent metastatic prostate…”
Get full text
Journal Article -
11
Predictors of survival from urachal cancer : A mayo clinic study of 49 cases
Published in Cancer (01-12-2007)“…Outcome results of a long-term analysis of urachal cancer using a new staging system are presented. The authors analyzed clinical outcomes from 49 patients…”
Get full text
Journal Article -
12
Risk factors for pancreatic neuroendocrine tumors: a clinic-based case-control study
Published in Pancreas (01-11-2014)“…Pancreatic neuroendocrine tumors (PNETs) are uncommon, and little is known about their risk factors and association with other cancers. We evaluated whether…”
Get full text
Journal Article -
13
Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma
Published in Neuro-oncology (Charlottesville, Va.) (01-05-2011)“…The objective of this phase II study was to evaluate the efficacy and safety of subcutaneous octreotide therapy for the treatment of recurrent meningioma and…”
Get full text
Journal Article -
14
A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors
Published in Investigational new drugs (01-07-2006)“…CS-682 (1-(2-C-cyano-2-deoxy-beta-D-arabino-pentofuranosyl)-N4-palmitoylcytosine) is a novel orally administered 2'-deoxycytidine-type antimetabolite, which…”
Get full text
Journal Article -
15
Impact of diabetes mellitus on clinical outcomes in patients undergoing surgical resection for pancreatic cancer: a retrospective, cohort study
Published in The American journal of gastroenterology (01-09-2014)“…Diabetes mellitus (DM) has a bidirectional association with pancreatic cancer (PaC); however, its effect on clinical outcomes has not been thoroughly…”
Get full text
Journal Article -
16
A Phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma
Published in Cancer (15-03-2003)“…BACKGROUND Recent laboratory and epidemiologic studies have suggested that green tea has antitumor effects in patients with prostate carcinoma. This Phase II…”
Get full text
Journal Article -
17
Older versus younger patients with metastatic adenocarcinoma of the esophagus, gastroesophageal junction, and stomach: A pooled analysis of eight consecutive North Central Cancer Treatment Group (NCCTG) trials
Published in International journal of oncology (01-03-2010)“…Whether elderly patients with metastatic esophageal, gastroesophageal, and gastric cancer do as well with chemotherapy as their younger counterparts was…”
Get full text
Journal Article -
18
Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma
Published in Liver transplantation (01-05-2000)“…Orthotopic liver transplantation (OLT) alone for unresectable cholangiocarcinoma is often associated with early disease relapse and limited survival. Because…”
Get full text
Journal Article -
19
Priming Tissue-specific Cellular Immunity in a Phase I Trial of Autologous Dendritic Cells for Prostate Cancer
Published in Clinical cancer research (01-06-2000)“…We attempted to induce therapeutic immunity against prostate-derived tissues in patients suffering from progressive hormone-refractory metastatic prostate…”
Get full text
Journal Article -
20
Topotecan in previously treated advanced urothelial carcinoma : an ECOG phase II trial
Published in Investigational new drugs (01-01-1998)“…[corrected] Chemotherapeutic agents are playing an increasing role in the management of urothelial carcinoma. Despite recent advances in the treatment of this…”
Get full text
Journal Article